139 related articles for article (PubMed ID: 21767977)
1. Podoplanin expression predicts prognosis in patients with oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy.
Kreppel M; Drebber U; Wedemeyer I; Eich HT; Backhaus T; Zöller JE; Scheer M
Oral Oncol; 2011 Sep; 47(9):873-8. PubMed ID: 21767977
[TBL] [Abstract][Full Text] [Related]
2. The role of clinical versus histopathological staging in patients with advanced oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy followed by radical surgery.
Kreppel M; Dreiseidler T; Rothamel D; Eich HT; Drebber U; Zöller JE; Scheer M
J Craniomaxillofac Surg; 2013 Jan; 41(1):22-7. PubMed ID: 22727901
[TBL] [Abstract][Full Text] [Related]
3. Histopathological assessment of tumour regression, nodal stage and status of resection margins determines prognosis in patients with oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy.
Wedemeyer I; Kreppel M; Scheer M; Zöller JE; Büttner R; Drebber U
Oral Dis; 2014 Apr; 20(3):e81-9. PubMed ID: 23746299
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant concurrent radiochemotherapy followed by surgery in advanced oral squamous cell carcinoma (OSCC): a retrospective analysis of 207 patients.
Freier K; Engel M; Lindel K; Flechtenmacher C; Mühling J; Hassfeld S; Hofele C
Oral Oncol; 2008 Feb; 44(2):116-23. PubMed ID: 17350327
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients.
Eich HT; Löschcke M; Scheer M; Kocher M; Bongartz R; Wacker S; Zöller JE; Müller RP
Strahlenther Onkol; 2008 Jan; 184(1):23-9. PubMed ID: 18188519
[TBL] [Abstract][Full Text] [Related]
6. Podoplanin expression in cutaneous head and neck squamous cell carcinoma--prognostic value and clinicopathologic implications.
Kreppel M; Krakowezki A; Kreppel B; Drebber U; Wedemeyer I; Mauch C; Zöller JE; Scheer M
J Surg Oncol; 2013 Mar; 107(4):376-83. PubMed ID: 22886751
[TBL] [Abstract][Full Text] [Related]
7. The prognostic relevance of lymph node ratio in patients with oral squamous cell carcinoma treated with neoadjuvant therapy regimen and radical surgery.
Rempel V; Safi AF; Drebber U; Nickenig HJ; Neugebauer J; Zöller JE; Kreppel M
J Craniomaxillofac Surg; 2018 Sep; 46(9):1659-1663. PubMed ID: 30196863
[TBL] [Abstract][Full Text] [Related]
8. Podoplanin and SOX2 expression in esophageal squamous cell carcinoma after neoadjuvant chemo-radiotherapy.
Saigusa S; Mohri Y; Ohi M; Toiyama Y; Ishino Y; Okugawa Y; Tanaka K; Inoue Y; Kusunoki M
Oncol Rep; 2011 Nov; 26(5):1069-74. PubMed ID: 21811761
[TBL] [Abstract][Full Text] [Related]
9. Podoplanin and VEGF-C immunoexpression in oral squamous cell carcinomas: prognostic significance.
dos Santos Almeida A; Oliveira DT; Pereira MC; Faustino SE; Nonogaki S; Carvalho AL; Kowalski LP
Anticancer Res; 2013 Sep; 33(9):3969-76. PubMed ID: 24023336
[TBL] [Abstract][Full Text] [Related]
10. Preoperative vs. postoperative radiochemotherapy in patients with N2 squamous cell carcinoma of the oral cavity.
Kreppel M; Eich HT; Brüggenolte C; Dreiseidler T; Rothamel D; Drebber U; Kübler A; Zöller JE; Scheer M
Oral Oncol; 2012 Oct; 48(10):1019-1024. PubMed ID: 22560339
[TBL] [Abstract][Full Text] [Related]
11. Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy.
Kawaguchi H; El-Naggar AK; Papadimitrakopoulou V; Ren H; Fan YH; Feng L; Lee JJ; Kim E; Hong WK; Lippman SM; Mao L
J Clin Oncol; 2008 Jan; 26(3):354-60. PubMed ID: 18202409
[TBL] [Abstract][Full Text] [Related]
12. Preoperative radiochemotherapy and radical resection for stages II to IV oral and oropharyngeal cancer: grade of regression as crucial prognostic factor.
Klug C; Wutzl A; Kermer C; Ploder O; Sulzbacher I; Selzer E; Voracek M; Oeckher M; Ewers R; Millesi W
Int J Oral Maxillofac Surg; 2005 May; 34(3):262-7. PubMed ID: 15741034
[TBL] [Abstract][Full Text] [Related]
13. High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer.
Xi H; Baldus SE; Warnecke-Eberz U; Brabender J; Neiss S; Metzger R; Ling FC; Dienes HP; Bollschweiler E; Moenig S; Mueller RP; Hoelscher AH; Schneider PM
Clin Cancer Res; 2005 Dec; 11(23):8341-7. PubMed ID: 16322294
[TBL] [Abstract][Full Text] [Related]
14. Outcome and histopathologic regression in oral squamous cell carcinoma after preoperative radiochemotherapy.
Driemel O; Ettl T; Kölbl O; Reichert TE; Dresp BV; Reuther J; Pistner H
Strahlenther Onkol; 2009 May; 185(5):296-302. PubMed ID: 19440668
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of podoplanin in oral cancer and its association with poor clinical outcome.
Yuan P; Temam S; El-Naggar A; Zhou X; Liu DD; Lee JJ; Mao L
Cancer; 2006 Aug; 107(3):563-9. PubMed ID: 16804930
[TBL] [Abstract][Full Text] [Related]
16. [Podoplanin expression in oral squamous cell carcinoma and leukoplakia and its correlation with lymph vessels density].
Zhang G; Guo ZL; Gao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Aug; 44(8):488-91. PubMed ID: 19961757
[TBL] [Abstract][Full Text] [Related]
17. Podoplanin expression in oral leukoplakia: prognostic value and clinicopathological implications.
Kreppel M; Kreppel B; Drebber U; Wedemayer I; Rothamel D; Zöller JE; Scheer M
Oral Dis; 2012 Oct; 18(7):692-9. PubMed ID: 22471854
[TBL] [Abstract][Full Text] [Related]
18. Co-expression of Bmi-1 and podoplanin predicts overall survival in patients with squamous cell carcinoma of the head and neck treated with radio(chemo)therapy.
Vormittag L; Thurnher D; Geleff S; Pammer J; Heiduschka G; Brunner M; Grasl MCh; Erovic BM
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):913-8. PubMed ID: 19215825
[TBL] [Abstract][Full Text] [Related]
19. Control of cell proliferation kinetics of tumor in neoadjuvant chemotherapy for advanced oral squamous cell carcinoma and its prognostic implications.
Noguchi M; Kinjyo H; Miyazaki A; Kubota H; Kohama G
Int J Clin Oncol; 2002 Jun; 7(3):138-44. PubMed ID: 12109514
[TBL] [Abstract][Full Text] [Related]
20. [Five year survival of patients with primary oral squamous cell carcinoma. Comparison of two treatment protocols in a prospective study].
Kessler P; Grabenbauer G; Leher A; Bloch-Birkholz A; Vairaktaris E; Neukam FW; Sauer R
Strahlenther Onkol; 2007 Apr; 183(4):184-9. PubMed ID: 17406799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
